- Home
- MLTX vs KOP Comparison
MLTX vs KOP Comparison
Compare MLTX & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- KOP
- Stock Information
- Founded
- MLTX 2021
- KOP 1988
- Country
- MLTX Switzerland
- KOP United States
- Employees
- MLTX N/A
- KOP N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- KOP Forest Products
- Sector
- MLTX Health Care
- KOP Basic Materials
- Exchange
- MLTX Nasdaq
- KOP Nasdaq
- Market Cap
- MLTX 595.6M
- KOP 550.1M
- IPO Year
- MLTX N/A
- KOP 2006
- Fundamental
- Price
- MLTX $9.82
- KOP $29.59
- Analyst Decision
- MLTX Buy
- KOP Strong Buy
- Analyst Count
- MLTX 9
- KOP 2
- Target Price
- MLTX $37.63
- KOP $52.50
- AVG Volume (30 Days)
- MLTX 12.2M
- KOP 135.4K
- Earning Date
- MLTX 11-07-2025
- KOP 11-07-2025
- Dividend Yield
- MLTX N/A
- KOP 1.10%
- EPS Growth
- MLTX N/A
- KOP N/A
- EPS
- MLTX N/A
- KOP 0.73
- Revenue
- MLTX N/A
- KOP $1,992,600,000.00
- Revenue This Year
- MLTX N/A
- KOP N/A
- Revenue Next Year
- MLTX N/A
- KOP $2.35
- P/E Ratio
- MLTX N/A
- KOP $39.87
- Revenue Growth
- MLTX N/A
- KOP N/A
- 52 Week Low
- MLTX $5.95
- KOP $22.99
- 52 Week High
- MLTX $62.75
- KOP $39.83
- Technical
- Relative Strength Index (RSI)
- MLTX 27.40
- KOP 68.28
- Support Level
- MLTX $8.92
- KOP $26.17
- Resistance Level
- MLTX $9.47
- KOP $27.39
- Average True Range (ATR)
- MLTX 0.62
- KOP 0.59
- MACD
- MLTX 1.54
- KOP 0.41
- Stochastic Oscillator
- MLTX 47.44
- KOP 100.00
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About KOP Koppers Holdings Inc.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.